Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)
Elutia's (ELUT) quarterly Total Non-Current Liabilities came in at $24.7 million in Q2 2026, down 62.92% year-over-year from $66.7 million in Q2 2025, and down 15.54% quarter-over-quarter from $29.3 million in Q1 2026.
Analysis
Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Elutia has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $24.7 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 62.92% year-over-year to $24.7 million; the TTM figure through Jun 2026 stood at $24.7 million (down 62.92% YoY), while the FY2025 annual figure was $31.6 million, down 52.42% from the prior year.
- Total Non-Current Liabilities came in at $24.7 million for Q2 2026 at Elutia, down from $29.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $76.5 million in Q3 2023 to a low of $24.7 million in Q2 2026.
- Average Total Non-Current Liabilities over 5 years is $58.0 million, with a median of $66.5 million recorded in 2024.
- Year-over-year, Total Non-Current Liabilities surged 83.13% in 2022 and sank 62.92% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $68.0 million in 2022, then advanced by 1.93% to $69.3 million in 2023, then dropped by 4.27% to $66.3 million in 2024, then tumbled by 52.42% to $31.6 million in 2025, then declined by 21.59% to $24.7 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $24.7 million in Q2 2026, $29.3 million in Q1 2026, and $31.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Elutia | 35.28 Mn | 15.39 Mn | 1.45 Mn | 24.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.74 Mn |
| Mar 31, 2026 | 29.29 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Sep 30, 2025 | 69.30 Mn |
| Jun 30, 2025 | 66.73 Mn |
| Mar 31, 2025 | 63.67 Mn |
| Dec 31, 2024 | 66.31 Mn |
| Sep 30, 2024 | 70.12 Mn |
| Jun 30, 2024 | 67.22 Mn |
| Mar 31, 2024 | 66.16 Mn |
| Dec 31, 2023 | 69.27 Mn |
| Sep 30, 2023 | 76.45 Mn |
| Jun 30, 2023 | 68.86 Mn |
| Mar 31, 2023 | 67.06 Mn |
| Dec 31, 2022 | 67.96 Mn |
| Sep 30, 2022 | 60.25 Mn |
| Jun 30, 2022 | 42.75 Mn |
| Mar 31, 2022 | 36.85 Mn |
| Dec 31, 2021 | 37.11 Mn |
| Sep 30, 2021 | 35.49 Mn |